CATX — Perspective Therapeutics Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Perspective Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 June 30th	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	6 M	12 M	12 M	12 M
Source:	10-K	10-KT	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-7.27	-7.33	-46.5	-79.3	-103
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	1.12	0.996	8.96	29	16.5
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1.85	0.094	2.3	31.8	1.68
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-7.71	-6.09	-36.9	-18.3	-82.5
Capital Expenditures	-0.284	-0.151	-1.09	-54.5	-12.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0	-28.7	25.5	-164	54.1
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities	-0.284	-28.8	24.4	-219	41.2
Financing Cash Flow Items	—	—	-0.065	0	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.056	0.028	0.785	289	10.3
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-7.94	-34.9	-11.8	52.2	-31